Product/Composition:- | Aceclofenac tablets |
---|---|
Strength:- | 100 mg |
Form:- | Oral Tablets |
Reference Brands:- | Aceclo(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Aceclofenac inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. It provides effective relief from osteoarthritis, rheumatoid arthritis, and musculoskeletal pain. Benefits include targeted anti-inflammatory effects, longer duration of action, and fewer gastrointestinal side effects compared to traditional NSAIDs.
Aceclofenac tablets are approved in the EU and several other countries for managing pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. In the EU, brands like Aceclo and Acegloc are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. Regulatory approval involves comprehensive clinical data, quality assurance, and pharmacovigilance commitments. In countries where aceclofenac is approved, manufacturers must adhere to national regulatory standards, ensuring safe use. For detailed dossier preparation, regulatory compliance, and registration assistance, visit PharmaTradz. We support efficient market access for aceclofenac tablets, helping you navigate complex regulatory landscapes seamlessly and ensuring adherence to European standards for safe, effective analgesic therapy.